August 5, 2016 — The Centers for Medicare and Medicaid Services (CMS) has reassigned MitraClip transcatheter mitral valve repair procedures to the diagnosis-related group (DRG) codes 228-229 for “Other Cardiothoracic Procedures, with and without major complications or comorbidities (MCCs)." The change is expected to boost reimbursement and allow more Medicare patients to have access to the technology. 

August 5, 2016 — Osprey Medical Inc. said it received commitments from investors for approximately $28 million Australian dollars for the market expansion of its DyeVert System to reduce contrast dose administrered to patients in the cath lab. The system helps protect patients from the harmful effects of iodine-based X-ray dye (contrast) used during commonly performed angiographic imaging procedures. 

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

 

August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of July based on website analytics:

1. FDA Approves First Totally Bioresorbable Stent

2. Dissolving Stents May Offer New Options in the Next Decade
CoreValve Evolut R, intermediate risk patients, european approval, CE mark

August 4, 2016 — Medtronic announced CE (Conformité Européenne) mark market clearnace for the self-expanding, recapturable and repositionable CoreValve Evolut R System to treat aortic stenosis patients who are at intermediate risk for open-heart surgery. The Evolut R System is the first transcatheter aortic valve replacement (TAVR or TAVI) device to obtain this expanded indication in Europe.

As more procedures move into the cath lab, growing complexity is fueling an increase in procedural volume and the need to carry a larger, more diverse inventory. Automated technology can help you more effectively manage high-value devices, allowing you to streamline inventory, minimize expired products, and increase charge capture. 

 

To view the white paper from Cardinal Health, please complete the registration form below.

 
 

August 3, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable Closer Vascular Sealing System (VSS) to achieve rapid hemostasis of femoral artery catheterizations. 

CT angiography, CTA, coronary CT, cardiac CT, SCCT, society of cardiovascular computed tomography, cardiac imaging

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting offers an in-depth review of all aspects of cardiac CT. The importance of the news from this conference is increasing each year as CT continues to see large expansion in the cardiovascular space, as recently found in a review of Medicare (CMS) data (read the article "Substantial Growth Found in Ordering of CTA Exams in Medicare Population"). 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now